AOD 9604 fat reduction in obese subjects Heffernan MA et al
Deboever N, Eisenberg M, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC , Roth J, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB
A method for preventing drug-induced ototoxicity in an individual in need thereof comprising intratympanic administration of a pharmaceutical composition comprising a therapeutic agent selected from a JNK inhibitor, a TRPV modulator, a MET channel inhibitor, and an otoprotectant to the individual in need thereof, wherein the pharmaceutical composition is administered prior to onset of therapy with the drug, and wherein the composition provides sustained release of the therapeutic agent into the ear for a period of at least 5 days after a single administration
In our naturopathic clinic in Phoenix we initially see improvement in energy and mental states